Fred Sanfilippo, MD, PhD

Professor of Pathology and Laboratory Medicine, and Health Policy and Management, Emory University; Director, Emory-Georgia Tech Healthcare Innovation Program; Medical Director, The Marcus Foundation

Fred Sanfilippo, MD, PhD career has been as a physician-scientist and academic leader. He is the Director of the Emory-Georgia Tech Healthcare Innovation Program, which has been developed with support from the Woodruff Fund and in coordination with the Georgia Clinical and Translational Science Alliance (CTSA) to enhance innovation in healthcare delivery research, education, and service. He is a Professor, Health Policy and Management at Emory University’s Rollins School of Public Health. He serves as Medical Director of The Marcus Foundation. He also serves on the Board of Directors for Alliance for Cell Therapy Now.

From 2007-2010 Dr. Sanfilippo served as Emory University Executive VP for Health Affairs, CEO of Emory’s Woodruff Health Sciences Center, and Chairman of Emory Healthcare. He joined Emory after serving at Ohio State University as Senior VP for Health Sciences and CEO of the OSU Medical Center from 2000-2007, Executive Dean for Health Sciences (2004-2007), and Dean of the OSU College of Medicine and Public Health (2000-2006). He led the formation of the Ohio State Center for Personalized Health, serving as its first director, and the Center for Integrative Health. From 2000-2007 he served as chair of the Board of Directors of Managed Health Care Systems, Inc., which administered the Ohio State University health plans, and from 2004-06 he co-chaired the strategic planning process to develop Your Plan for Health (YP4H).

From 1993 to 2000, Dr. Sanfilippo was the Baxley Professor and Director of the Department of Pathology at Johns Hopkins University, and Pathologist-in-Chief at the Johns Hopkins Hospital. He led the formation of the Johns Hopkins Comprehensive Transplant Center, serving as its first Director of Research. Prior to Johns Hopkins, Dr. Sanfilippo was on the Duke University faculty from 1979-1993, rising to Professor of Pathology, Surgery, and Immunology. At Duke he also served as Director of the Duke-VAMC Immunogenetics-Transplantation Laboratory, Director of the Duke Immunopathology Lab, and Chief of the Renal and Transplant Pathology services.

As a leader, Dr. Sanfilippo has been active in academic medicine, transplantation, and pathology. He has served on the editorial board of 13 professional journals, been invited to speak at some 200 academic and scientific venues, and elected president of seven academic and professional organizations. He has been a consultant to over 80 university, government, and corporate institutions. As an educator, he has mentored 33 graduate students and fellows, and led the creation of numerous new courses, degree programs, departments, and centers at four institutions. As a scientist, he has published over 250 articles, been awarded three patents, and granted over $30 million in personal research support as principal investigator of R01, P01, and U01 grants from the NIH, as well as from the VA and industry.

Dr. Sanfilippo earned his BS and MS degrees in physics from the University of Pennsylvania, and his MD and Ph.D. in immunology as a Medical Scientist Training Program Fellow at Duke University. He did his residency training in Pathology at Duke University Hospital, receiving Board certification in Anatomic and Clinical Pathology, and Immunopathology.